NCT00504244View on ClinicalTrials.gov

Myfortic Versus Azathioprine in Systemic Lupus Erythematosus

PHASE3TerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

switch to Myfortic

Myfortic 2 dd 720 mg

DRUG

continuation of azathioprine

Azathioprine 2 mg/kg

Trial Locations (1)

3015 CE

Erasmus MC, Rotterdam

Sponsors

Collaborators (1)

Novartis Pharmaceuticals
All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Erasmus Medical Center

OTHER